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AbstrAct
We aimed at evaluating the association between intestinal Lactobacillus sp. 
composition and their metabolic activity with the host metabolism in adult and elderly 
individuals. Faecal and plasma metabolites were measured and correlated to the 
Lactobacillus species distribution in healthy Estonian cohorts of adult (n = 16; < 
48 y) and elderly (n = 33; > 65 y). Total cholesterol, LDL, C-reactive protein and 
glycated hemoglobin were statistically higher in elderly, while platelets, white blood 
cells and urinary creatinine were higher in adults. Aging was associated with the 
presence of L. paracasei and L. plantarum and the absence of L. salivarius and L. 
helveticus. High levels of intestinal Lactobacillus sp. were positively associated with 
increased concentrations of faecal short chain fatty acids, lactate and essential amino 
acids. In adults, high red blood cell distribution width was positively associated with 
presence of L. helveticus and absence of L. ruminis. L. helveticus was correlated to 
lactate and butyrate in faecal waters. This indicates a strong relationship between the 
composition of the gut Lactobacillus sp. and host metabolism. Our results confirm that 
aging is associated with modulations of blood biomarkers and intestinal Lactobacillus 
species composition. We identified specific Lactobacillus contributions to gut metabolic 
environment and related those to blood biomarkers. Such associations may prove 
useful to decipher the biological mechanisms underlying host-gut microbial metabolic 
interactions in an ageing population.
INtrODUctION
The human intestinal tract harbours a large and 
complex community of microorganisms [1] that varies 
widely across the population. Studies report more than 
1,000 different species of bacteria present in the large 
intestine of healthy adults depending on the technic used 
to asses this number [1-5]. The complex composition 
of the gut microbiota is now recognized to be strongly 
involved in host metabolic and immunologic homeostasis 
[6, 7]. This impact on host health status is partially due to 
the important metabolic role played by the gut microbial 
ecosystem during digestion [8]. This symbiotic balance 
is extremely complex to understand due to a multitude 
of factors affecting its modulation, such as age, diet and 
lifestyle [9, 10]. Numerous publications have explored the 
impact of specific phyla and genera on host health. For 
example, higher Bacteroidetes/Firmicutes ratio has been 
associated with lean constitution [11-13] in rodents and 
lower plasma glucose concentration in diabetic humans 
[14].
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Lactobacillus are part of the Firmicutes genus, 
to date over hundred species have been described of 
which 30% are found in the human gastro intestinal (GI) 
track [15]. Lactobacillus species are commonly used 
as probiotics because of their ability to protect the host 
against pathogen invasion, improve intestinal barrier 
function, provide metabolic and immunologic health-
promoting properties [16]. However, contradictory 
results have been published regarding the possible 
association of some Lactobacillus species with host 
metabolic homeostasis. For example, although L. casei 
and L. gasseri have been often associated with beneficial 
metabolic outcomes against obesity and diabetes [17, 18] 
some studies have shown a positive association between 
a higher diversity of Lactobacillus sp. and increased BMI 
and glycaemia in humans [19]. In addition, the genome 
characterization of some Lactobacillus sp. strongly 
associated with high BMI has revealed a lack of enzymes 
involved in carbohydrate metabolism [20-22]. Moreover, it 
has been shown that within this genus, some Lactobacillus 
probiotic strains, such as Lactobacillus acidophilus, 
L. casei, and L. rhamnosus, induced differential gene-
regulatory transcriptional networks and pathways in 
the human mucosa [22]. In another study, L. reuteri 
was found predominantly associated with obese adults 
compared to lean subjects [23], raising questions about 
the overall impact of some of these Lactobacillus species 
on the host metabolic homeostasis. As a consequence, a 
recently published meta-analysis on the impact of specific 
Lactobacillus species on weight gain [24] highlighted the 
urgency to explore the specific metabolic impact of species 
and even strains on the host. This further supports that 
every Lactobacillus probiotic strain triggers a specific host 
response that must be considered for a more personalised 
approach to functional food [25].
Elderly ( > 65 years) are the fastest growing 
subpopulation in the world. It has been shown that 
aging increased the viable count of Lactobacillus 
with substantial changes in species prevalence [26-
28]. Coincidently, the high inter-individual variability 
of the Lactobacillus species distribution is enhanced 
by age variations [19]. Elderly experience a profound 
modification in the composition of their gut microbiota 
[29], which has been associated in several studies with loss 
of immune functions and increased cardiovascular disease 
risk. Yet, it is not clear how the Lactobacillus genus 
impacts host metabolism. Thus, assessing the potential 
implication of the Lactobacillus population composition 
and its metabolic activity on physiological modifications 
occurring with aging is important for future corrections of 
microbial dysbiosis associated with age. Moreover, there 
is a lack of information about the metabolic activity of the 
gut microbial ecosystem in relation with Lactobacillus sp. 
composition. 1H NMR-based metabonomics is a powerful 
approach to identify the missing relationships between 
the gut microbial composition, gut metabolites and the 
host health [30-32]. To date, only a few publications have 
addressed the impact of specific Lactobacillus species on 
the metabolic profile of rat biofluids and gut tissues [33].
In this study we aimed at evaluating the impact of 
intestinal Lactobacillus sp. composition on several blood 
biomarkers of metabolic homeostasis that may be altered 
with age. To evaluate such association, fecal samples 
collected from two cohorts of healthy adult (n = 16) and 
elderly individuals (n = 33) recruited in previous studies 
[19] were analysed using a metabonomics approach. 
We used volunteers that formed a cohort of elderly 
individuals where the impact of a profile of Lactobacillus 
sp. on anthropometric parameters (white blood cell count 
and oxidized LDL) had been investigated [34]. We also 
used volunteers derived from a cohort of healthy adults 
and elderly where we questioned the impact of the 
Lactobacillus profile on BMI and glycaemia [19]. In this 
work, we present unexplored associations between the 
population of Lactobacillus and host metabolism in these 
two age groups using a metabonomics approach.
rEsULts
Association between physiological modifications 
of blood biomarkers of homeostasis with aging
Clinical indices reflecting the general homeostasis 
of all participants in both groups are summarized in Figure 
1. Levels of total cholesterol, low-density lipoproteins 
(LDL), high sensitivity C-reactive protein (hs-CRP) and 
glycated hemoglobin (HbA1C) were significantly higher 
in elderly compared with adults (p = 0.03; p = 0.001; p < 
0.001; p = 0.002, respectively). To the contrary, platelets, 
white blood cell count and urinary creatine (U-Creatine) 
were higher in adults (p = 0.002; p = 0.007; p = 0.026, 
respectively).
In order to identify potentially hidden relationships 
between blood markers presented in Figure 1, a Spearman 
correlation coefficient (r) was calculated between each 
blood biomarker independently and with age (Figure 
2). As expected, blood biomarkers related to immunity 
and inflammation were clustered together. Similarly, 
hemoglobin parameters (i.e. red blood cell, hematocrit 
and hemoglobin) formed a distinct cluster. As observed 
in Figure 1, age was negatively correlated with platelet, 
monocyte, lymphocyte and IgG but positively correlated 
with total cholesterol and LDL levels. Interestingly, a 
negative correlation between RDW-CV and corpuscular 
parameters (i.e. MCV, MCHC and MCH) was also 
observed. 
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Gut microbial Lactobacillus sp. composition is 
associated with age and blood clinical indices
In order to evaluate the potential implication of 
the gut Lactobacillus sp. composition on health, the 
association between the profile of Lactobacillus species 
and twenty-six physiological parameters described in 
Figure 1 (including age, immunological indices and 
plasma biochemical biomarkers) was evaluated using 
O-PLS regressions. Since some parameters were not 
available for the overall cohort, some associations were 
either evaluated for both age groups together (Figure 
3) or separately (Figure 4), as appropriate. Models 
were selected for further investigations when the Q2Y 
value was greater than an arbitrary threshold of 0.20 as 
presented in Figures 3A and 4A. Based on these criteria, 
models fitting red cell distribution width (RDW) levels, 
age and IgM concentrations were selected. Validations of 
these models were obtained by random permutation test 
(see material and methods). As a result, the IgM model 
was further rejected due to a p-value exceeding the risk 
alpha threshold of 5% (p-value = 0.062). As previously 
described, aging was associated with the presence of L. 
paracasei (r2 = 0.48) and L. plantarum (r2 = 0.30) and 
the absence of L. salivarius (r2 = 0.37) and L. helveticus 
(r2 = 0.34) in this cohort (Figure 3C). This new analysis 
revealed that high RDW levels were positively associated 
with the presence of L. helveticus (r2 = 0.29) and the 
absence of L. ruminis (r2 = 0.36) (Figure 4C). 
total population of Lactobacillus impacts faecal 
metabolic profiles
Faecal metabolic profiles reflect the overall 
metabolic activity of the gut microbial ecosystem. In order 
to get insights into the contribution of specific bacterial 
Figure 1: The figure represents the average measurement of several blood biomarkers for adults (open bars) and 
elderly (close bars). Results are presented as mean ± SD; **p < 0.01; *p < 0.05. Key: MCV, mean corpuscular volume; MCH, mean 
corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW-CV, red cell distribution width; Hs-CRV, high 
sensitivity C-reactive protein; HbA1C, glycated hemoglobin; LDL, low density lipoprotein; HDL, high density lipoprotein.
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Figure 2: Heat map of the Spearman correlation (r) between blood biomarkers. Correlations were performed between 
each blood biomarker for the overall population. Key: MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, 
mean corpuscular hemoglobin concentration; RDW-CV, red cell distribution width; Hs-CRV, high sensitivity C-reactive protein; HbA1C, 
glycated hemoglobin; LDL, low density lipoprotein; HDL, high density lipoprotein. *Significant correlation (p < 0.05) after correction 
using Benjamini and Hochberg false discovery rate method with a false discovery rate Q = 0.20.
Figure 3: Association of Lactobacillus species profile with physiological parameters. A. Histogram of descending Q2Y values 
derived from O-PLS models performed using the profile of Lactobacillus species as X matrix and the quantitative levels of 7 physiological 
parameters as independent response predictors for the overall population (N = 32). b. Scores derived from the O-PLS model using age 
as a response predictor (R2Y = 0.51, R2X = 0.16, Q2 = 0.25, p-value = 0.003 and p-value FDR = 0.006). c. Loadings plot derived from 
the same model as in b.; Lactobacillus species pointing upward on the loadings plot are positively correlated with the elderly group, and 
Lactobacillus species pointing downward are correlated with the adult population.
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Figure 4: Association of Lactobacillus species profile with blood biomarkers in adult individuals. A. Histogram of 
descending Q2 values calculated from O-PLS model performed using the profile of Lactobacillus species as X matrix and the quantitative 
levels of 21 blood biomarkers as independent response predictors for the adult population only. b. Scores derived from the O-PLS model 
using RDW levels as a response predictor (this model uses one orthogonal component; R2Y = 0.95, R2X = 0.28, Q2Y = 0.67, p-value = 0.005 
and p-value FDR = 0.013). c. Loadings plot derived from the same model as in b., Lactobacillus species pointing upward on the loadings 
plot are positively correlated with RDW levels. 
Figure 5: High total count of Lactobacillus sp. is associated with higher faecal SCFAs, lactic acid and amino acid levels. 
A. O-PLS scores projection of all individuals according to the decimal logarithm of total Lactobacillus counts. This model is derived 
from 1H-NMR spectra of faecal waters using the log of total Lactobacillus counts as a response predictor. b. Metabolic contribution of 
SCFAs, organic acids and amino acids to the same model (loadings plot). Metabolites pointing upwards are positively correlated with high 
Lactobacillus levels.
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species to the gut metabolic environment, we used a series 
of linear regressions using O-PLS algorithms. Hence, 
impact of total Lactobacillus count on the faecal metabolic 
profile was evaluated by O-PLS regression using the 
decimal logarithm of Lactobacillus concentration as a 
response predictor. Results displayed in Figure 5 reveal 
a strong correlation (R2Y = 0.44, Q2 = 0.27 and p-value = 
0.002) between the Lactobacillus counts found in faeces 
and individual’s faecal metabolic profiles. High levels of 
Lactobacillus sp. were positively correlated with increased 
SCFAs (acetate, propionate and butyrate), lactic acid and 
essential amino acid (tyrosine, phenylalanine, leucine, 
isoleucine, valine and lysine) levels (Figure 5B).
L. helveticus shows specific contributions to fecal 
metabolic profiles
In order to determine the individual impact of 
the presence of sixteen Lactobacillus species on faecal 
metabolic profiles regardless of age, O-PLS models 
were performed using bacterial presence or absence as 
a response predictor (presence was coded 1 and absence 
was coded 0 in the response vector). Only the presence 
of L. helveticus appeared to significantly influence faecal 
metabolic profiles in this cohort (R2Y = 0.50, Q2Y = 0.27, 
p-value = 0.008) (Figure 6). Butyrate, lactate and glucose 
levels were positively correlated with the presence of L. 
helveticus. 
DIscUssION
Worldwide, the increased percentage of elderly 
in the population has steered attention towards a better 
understanding of physiological changes accompanying 
aging. Among them, decreased digestion, immune 
function [35, 36] and increased risk of developing 
metabolic syndrome during senescence are of major 
importance. In this context, understanding the regulatory 
mechanisms triggering such changes will significantly 
help to improve elderly’s quality of life. As there is 
increasing evidence that the gut microbiota, and more 
specifically the Lactobacillus genus, may be a key player 
in these transformations [29, 37], we analysed various 
blood biomarkers of homeostasis and quantified the profile 
of Lactobacillus sp. in two age groups. Although both 
groups were considered healthy, elderly presented lower 
counts of white blood cells, especially lymphocytes and 
monocytes (Figure 1). Our results also showed that blood 
metabolic parameters in elderly differed from the adults 
because of higher cholesterol content (total cholesterol 
and LDL), and higher insulin resistance (HbA1c) (Figure 
1). These results are consistent with previously assessed 
immunologic and metabolic variations related to aging 
[38, 40], which supports the use of this cohort to evaluate 
associations between these biomarkers and the profile of 
gut Lactobacillus. 
We further looked for associations between the total 
count and the composition of intestinal lactobacilli species 
with age, BMI and every blood biomarker presented in 
Figure 1. These results were in accordance with previously 
described data where aging was characterized by a 
modification of the Lactobacillus population [41, 42]. L. 
paracasei and L. plantarum were predominantly found 
in elderly whereas L. salivarius and L. helveticus were 
in higher levels in adults. We did not observe here that 
L. acidophilus was more predominantly found in adults 
than in elderly as previously published, which is likely 
a consequence of the use of smaller subgroups that may 
have impacted the statistical power of the present analysis 
Figure 6: Presence of L. helveticus was associated with an increase in butyrate and lactate faecal counts. A. Scores plot 
derived from the O-PLS model using the absence (dark blue) or presence (light pink) of L. helveticus as a response predictor. The calculated 
scores (x axis) are plotted against the cross-validated scores (y axis). b. Loadings plot derived from the same model showing the metabolic 
contribution of butyrate, lactate and glucose. Metabolites pointing upwards correlate with the presence of L. helveticus.
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[19]. In addition, it is possible that variations in diet may 
be responsible for inconsistent results between studies. 
Nevertheless, since modifications of the gut microbiota 
over a lifespan have been documented worldwide, it 
is likely that other factors are involved. None of the 
immunologic and metabolic biomarkers differentiating 
elderly from adults (i.e. total cholesterol, LDL, white 
blood cells, lymphocyte, monocyte, U-creatinine, hs-
CRP, platelet, and glycated hemoglobin) generated robust 
O-PLS models when associated with the species profile of 
Lactobacillus. The work presented here was a focus on the 
influence of Lactobacillus species on the host metabolism 
and therefore we did not perform a deep sequencing 
analysis of the microbial ecosystem that would have 
been necessary to identify co-varying microbes that may 
contribute to a potential impact of the whole Lactobacillus 
genus on the host metabolism.
Interestingly, a strong model was found when the 
red cell distribution width (RDW-CV) was used as a 
response predictor for the Lactobacillus sp. composition 
in the adult population. This blood biomarker was 
positively associated with the presence of L. helveticus 
and the absence of L. ruminis. No significant variation 
of the RDW-CV was found between the two age groups, 
indicating that this result was not directly related to 
ageing. The three other red blood cell biomarkers: 
mean corpuscular volume (MCV), mean corpuscular 
hemoglobin concentration (MCHC) and mean corpuscular 
hemoglobin (MCH) were negatively associated with 
RDW-CV and are often measured as indicators of 
anemia [43]. High RDW-CV and low MCV are generally 
associated with microcytic anemia [44]. This type of 
anemia can be caused by iron, vitamin B12 and/or folic acid 
deficiency in the bloodstream [45-47]. Such deficiency 
usually results from diet depletion and/or poor absorption 
by the gut barrier of these methyl donors. Interestingly, 
the presence of L. helveticus, a bacterium mostly found 
in adults that is not able to synthetize vitamin B12, was 
positively associated with RDW-CV [48]. It has been 
shown that this Lactobacillus species expresses a receptor 
for vitamin B12 [49] resulting in significant depletion of the 
vitamin B12 in milk during fermentation [50]. Therefore 
the presence of L. helveticus in the gut might significantly 
decrease the bioavailability of vitamin B12 for the host 
resulting in increased risks of anemia.
Concurrently, we observed a negative correlation 
between the presence of L. ruminis and RDW-CV. 
Although the sequenced genome of L. ruminis showed its 
inability to produce vitamin B12 [51], a recent publication 
investigating the potential of several lactobacilli as 
vitamin producers demonstrated that L. ruminis possessed 
all the genes necessary for chorismate biosynthesis [52]. 
Chorismate is a precursor of folic acid, the insufficiency of 
which is also linked to microcytic anemia. Since L. ruminis 
appears to lack various genes necessary to complete folate 
biosynthesis, it can therefore be hypothesized that L. 
ruminis secrets chorismate in the gut environment, which 
is then used as a substrate by other commensal bacteria 
for folic acid production that may be made available to the 
host [53]. This hypothesis will have to be further tested to 
validate the potential opposite roles of L. helveticus and L. 
ruminis in vitamin B12 bioavailability.
NMR-based metabonomics was used to measure 
all detectable low molecular weight metabolites in 
fecal waters as a reflection of the metabolic activity of 
the gut microbial ecosystem. This approach has proved 
particularly helpful to detect relationships between the 
gut microbial composition and the host metabolism [30 
, 32]. To date only a few publications have addressed the 
impact of specific Lactobacillus species (L. acidophilus 
and L. paracasei) on the metabolic profile of rat biofluids 
and gut tissues [33]. Here, we found no correlation 
between faecal metabolic profiles and blood biomarkers, 
indicating that the overall metabolic activity of the gut 
microbial ecosystem may not be directly associated with 
modifications of blood biochemistry. Nonetheless, it was 
possible to identify significant associations between the 
gut profile of Lactobacillus sp. and faecal water metabolic 
profiles. Higher counts of total lactobacilli were associated 
with a higher content in essential amino acids (tyrosine, 
phenylalanine, leucine, isoleucine, valine and lysine) and 
SCFA (butyrate, propionate and acetate) and lactate. This 
is consistent with the diversity of metabolic pathways used 
by intestinal Lactobacillus sp. for degradation of a large 
range of metabolites including carbohydrates, lipids and 
proteins [54]. Because Lactobacillus sp. are not the main 
SCFAs producers, this suggests cross-feeding interactions 
with other SCFAs-producing bacteria and indicates that 
Lactobacillus sp. markedly contribute to the overall 
SCFAs content in the lumen. SCFAs production by the gut 
microbiota is of crucial importance because of their wide 
range of action on the host [55]. Indeed, SCFAs have been 
associated with a protective effect against colon cancer 
development [56, 57] and cardiovascular disease risk [58]. 
In this study, elderly presented higher Lactobacillus count 
than adults. However, 1H-NMR faecal metabolic profiles 
did not reveal any significant difference between adults 
and elderly, indicating that SCFAs concentrations were 
not significantly different between the two age groups 
despite the difference in total Lactobacillus count. This 
is not surprising since many bacterial species are able to 
produce SCFAs from the fermentation of carbohydrates 
and proteins [59], and the increase in total Lactobacillus 
in elderly may not be sufficient to increase the overall 
counts of SFCAs in faecal waters. This observation is in 
contradiction with previous studies, which demonstrated 
that age was associated with an overall reduction in faecal 
excretion of SCFAs related to decreased bacterial diversity 
[60, 61]. 
Regardless of age, L. helveticus were strongly 
associated with variations in faecal metabolic profiles. 
The presence of L.helveticus was associated with 
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increased butyrate and lactate levels in faecal waters, 
indicating the significant metabolic contribution of L. 
helveticus to the gut metabolic environment. L. helveticus 
is a strictly homofermentative bacteria that can only 
produce lactate from the fermentation of saccharides, 
and is not a butyrate producer. Therefore, the correlation 
with butyrate is indicative of bacterial cross-feeding 
where lactate produced by L. helveticus may be used by 
butyrate-producing bacteria. Such co-metabolism has been 
demonstrated in the human gut where several bacteria 
including Eubacterium hallii and Anaerostipes caccae use 
lactate to produce butyrate [62].
In conclusion, this study provides new insights 
into the complex metabolic network existing between 
the host and its gut microbiota. The global composition 
of Lactobacillus sp. significantly impacts the metabolic 
environment of the gut, promoting the total amount 
of lactate, SFCAs and essential amino acids. We also 
highlighted the unique metabolic contribution of specific 
Lactobacillus species to the host-gut microbial metabolic 
interactions. We therefore confirm that a bacterial genus 
can play an important role in host health and demonstrate 
that specific metabolic contributions of independent 
species should also be evaluated. This emphasizes the 
need for a deeper understanding of the host-gut bacterial 
metabolic interactions that must pave the way for a 
personalized approach to probiotic supplementation.
MAtErIALs AND MEtHODs
study population
We used faecal samples, blood biomarkers and 
Lactobacillus profiles of two healthy Estonian cohorts 
of adult (n = 16; 20 48 y) and elderly (n = 33; 65-81 y) 
individuals. The experimental design applied to these 
cohorts was approved by the Ethics Committee of the 
Medical Faculty of the University of Tartu with approvals 
no. 139/16 20.06.2005, no. 158/10, 26.03.2007 and no. 
184/T-10, 26.08.2009. The present study was conducted 
according to the guidelines laid down in the Declaration 
of Helsinki.
All 16 adults and 17 of the elderly subjects 
were recruited from the trials ISRCTN38739209 and 
ISRCTN15061552, respectively, assessing the impact of a 
probiotic provided by Bio-competence Centre of Healthy 
Dairy Products LLC, as previously described [19]. For the 
purpose of this publication, we only analysed the data of 
baseline at recruitment pre-intervention. The additional 
sixteen elderly were selected from the registry of family 
doctors and orthopedists of the Tartu University Hospital, 
Estonia, before performing elective orthopedic surgery, 
according to inclusion and exclusion criteria as presented 
in the original publications [19, 34]. The selection of the 
final cohort (N = 49) of individuals included in this study 
was based on the availability of frozen faecal samples to 
perform 1H-NMR metabolic profiling. All individuals in 
both age groups were healthy and followed a standard 
Western-type diet, typically rich in potatoes, vegetables, 
meat, eggs but characterised also by a high content 
of fibre (rye bread, oat/wheat/rice porridge) and dairy 
products, vegetable seed oils, margarine and non-alcoholic 
beverages.
Faecal Lactobacillus species distribution assessed by 
real-time quantitative PCR have been previously published 
by Stsepetova et al. [19]. These data were used in order to 
evaluate potential association between the Lactobacillus 
sp. composition and several blood biomarkers and faecal 
metabolic profiles. Some of the blood clinical indices have 
been published previously for the elderly and adult cohort 
but not compared to each other and put in relationship 
with the Lactobacillus sp. composition and its metabolic 
activity [34, 63].
sample collection and preparation
Fresh stool samples were placed into sterile 
containers. The samples collected at home or at hospital 
were kept in a domestic refrigerator at 4°C for no more 
than 2h before transportation to the laboratory. Upon 
arrival, samples were mechanically homogenized with a 
sterile spatula, divided into aliquots and stored at -70°C 
until future DNA isolation and molecular microbiological 
analysis.
Molecular analysis of Lactobacillus sp. in fecal 
samples
Methods for quantitative and qualitative molecular 
analysis of Lactobacillus sp. in feces have been described 
in a previous study [19]. DNA was extracted from stool 
samples using a QIAamp DNA stool mini kit (Qiagen 
N.V.) with some modifications. 1g of feces was suspended 
in 10 mL of PBS buffer and homogenized. 0.3 g of 0.1 mm 
zirconia/silica beads and 1.4 mL of ASL solution from the 
stool mini kit was added to 1 mL of pellet cells. The tubes 
were then agitated for 3 minutes at a speed of 5000 rpm in 
a mini-bead beater (Biospec Products Inc.). The protocol 
was then continued as described by the manufacturer 
(Qiagen N.V.). 
In order to establish a quantitative assay, we cloned 
plasmids containing the amplified region of the target 
bacteria L. paracasei using the pGEM-T vector system 
(Promega, Madison, WI, USA) [64]. Quantification of 
target DNA was achieved by using serial tenfold dilution 
from 102 to 109 plasmid copies of the previously quantified 
plasmid standards. Real-time PCR was performed with 
the ABI PRISM 7500 HT Sequence Detection System 
(Applied Biosystems, Bedford, MA, USA) using optical-
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grade ninety-six-well plates. The PCR was performed on 
a total volume of 25 µL using SYBR Green PCR Master 
mix (Applied Biosystems). Each reaction included 150 ng 
of template DNA, 12.5 µL of SYBR Green PCR Master 
mix (Applied Biosystems) and 2 mM of each primer 
[65]. The conditions were set as follows: 2 min at 50°C 
and 10 min at 95ºC, followed by forty cycles consisting 
of denaturation at 95°C for 15 s, and annealing and 
elongation at 60°C for 1 min. Data analysis was conducted 
with Sequence Detection Software version 1.6.3, supplied 
by Applied Biosystems. 
The Lactobacillus species-specific qualitative 
PCR was carried out by primers targeted on the 16S 23S 
ribosomal RNA intergenic spacer region [66]. A reaction 
mixture (50 µL) consisted of 10X reaction buffer, a 200 
µM concentration of each deoxynucleoside triphosphate, 
1 µM of each primer, 100 ng of bacterial DNA (extracted 
from the faecal samples) and 1.5 U of HotStar Taq 
Plus DNA polymerase (Qiagen). The amplification 
program consisted of predenaturation at 94ºC for 5 min, 
followed by thirty-five cycles of 94°C for 30 s, 30 s at 
the appropriate annealing temperature [19], and finally 
72°C for 30 s. A cycle of 72°C for 10 min concluded the 
program. 
blood biochemistry
Blood samples were obtained in the early morning 
after 8 h of fasting. Samples were drawn from the 
antecubital vein with a vacutainer into heparinised 
tubes and immediately stored (on ice) at 4ºC. Data 
of hematological indices: hemoglobin, red blood 
cells, leukocytes, lymphocytes, monocytes, basophil, 
eosinophil, neutrophil, platelets, red cell distribution 
width (RDW-CV), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin concentration (MCHC), 
mean corpuscular hemoglobin (MCH), hematocrit (HCT); 
inflammatory indices: white blood cells count (WBC), 
high sensitivity C-reactive protein (hs-CRP); metabolic 
indices: plasma glucose, glycated hemoglobin (HbA1C), 
total cholesterol, oxidized LDL (ox-LDL), low density 
lipoproteins (LDL-C), high density lipoproteins (HDL-C) 
and triglycerides (TG); immunological: immunoglobulin 
E (IgE), immunoglobulin M (IgM), immunoglobulin G 
(IgG), immunoglobulin A (IgA); and urinary creatinine 
(U-creat) were performed with standard laboratory 
methods using certified assays in the clinical laboratory of 
the Tartu University Clinics, Estonia.
Intervals for routine laboratory tests proposed by the 
Nordic Reference Interval Project (NORIP, http://www.
furst.no/norip/) were used as references.
Extraction of polar metabolites
Faeces were homogenized in 1 mL of phosphate 
buffer (prepared in 9:1 D2O/H2O and 0.05 % sodium 
3-(tri-methylsilyl)propionate-2,2,3,3-d4 (TSP) as a 
1H 
NMR reference) for 5 min at T = 1/25 in a tissue lyser 
(TissueLyser LT, Qiagen). Samples were then centrifuged 
for 10 minutes at 22000 g. Supernatants were removed 
into new Eppendorf tubes and 500 μL of faecal water 
extract were transferred to 5mm NMR glass tubes for 
analysis. 
1H-NMr -based metabonomics
1H NMR spectra of faecal waters were acquired 
on a Bruker Avance DRX 700 MHz NMR Spectrometer 
(Bruker Biopsin, Rheinstetten, Germany) operating at 
700.19 MHz using a standard 1-dimensional (1D) pulse 
sequence [recycle delay (RD)-90°-t1-90°-tm-90°-acquire 
free induction decay (FID)] with water suppression 
applied during RD of 2 s and the mixing time (tm) of 100 
ms and a 90 degree pulse set approximately at 10 μs. For 
each spectrum, a total of 256 scans were accumulated into 
32 K data points with a spectral width of 12019 Hz. A 
range of 2D NMR spectra was performed on the same 
equipment on selected samples, including correlation 
spectroscopy (COSY) NMR spectroscopy. The FIDs 
were multiplied by an exponential function corresponding 
to 0.3 Hz line broadening. All spectra were manually 
phased, baseline corrected and calibrated to the chemical 
shift of TSP (δ 0.00) in MNova NMR version 8 (Mestrelab 
Research, Spain). Metabolites were assigned using 2D 
NMR experiments, data from literature [67] and our in 
house database of standards.
statistical analysis
Statistical analysis of blood biochemical markers 
was performed using R 3.0.2 (A Language and 
Environment, http://www.r-project.org) and GraphPad 
Prism version 4.00 for Windows (GraphPad Software, San 
Diego, CA). Clinical and biochemical data were expressed 
as mean ± standard. Adults and elderly were compared 
by t-tests or the Wilcoxon rank sum test according to the 
distribution of data adjusted for multiple comparisons. 
Differences were considered statistically significant if the 
p-value was strictly inferior to 0.05.
Spearman correlation coefficients were calculated 
between every blood markers independently and with age 
using Matlab software (The Mathworks, version R2013a). 
Statistical significance was evaluated using Benjamini and 
Hochberg false discovery rate correction (Q = 0.20, n = 
31).
Prior to analysis, all 1H-NMR spectra were 
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digitalized and imported into Matlab version R2013a. 
The residual water signal was removed between 4.70 
and 5.10 ppm. All spectra were then mean centered and 
scaled to unit variance. Principal Component Analysis was 
used to observe the general variation in the dataset and 
detect potential outliers. Data were then analysed using 
orthogonal projection to latent structure (O-PLS) where 
1H-NMR spectra were used as a matrix of independent 
variables (X) for modeling age, microbial composition 
and blood marker concentration as predictors (Y). The 
following parameters were considered for each O-PLS 
model: R2Y (goodness of fit: percentage of Y explained 
by the model) and Q2Y (the goodness of prediction: 
percentage of Y predicted after 7-fold cross validation). 
Significance of selected models was validated by 500 
random permutation tests.
In order to identify specific metabolic associations 
with individual bacterial species, a similar statistical 
approach was adopted using O-PLS regression analysis 
where the Lactobacillus species composition was used as 
a matrix of independent variables (X) for modeling blood 
physiological parameters (Y). The same parameters as 
the one described for the O-PLS analysis using 1H-NMR 
spectra were considered for model selection. p-values 
obtained by random permutation tests were corrected 
using the Benjamini & Hockberg false discovery rate 
method (Q = 0.20).
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